Cantor Fitzgerald reiterated its Overweight rating on ORIC Pharmaceuticals (NASDAQ:ORIC), currently trading at $13.39, after an incident involving a potential news leak. According to InvestingPro data ...
Cantor Fitzgerald reiterated its Overweight rating on Applied Materials (NASDAQ:AMAT) with a steady price target of $220.00, above the current analyst consensus high target of $250. The firm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback